Disease/Infection News

RSS

UCL-led team develops new technique to find resistant TB faster

The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.

From Oxford Gene Technology 13 May 2015

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

A simple blood test can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy, according to a report in the May issue of Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.

13 May 2015

FDA licenses Protein Sciences' Pearl River, NY facility to manufacture Flublok influenza vaccine

Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration licensed its Pearl River, NY manufacturing facility for the commercial manufacturing of Flublok influenza vaccine. Flublok is the world's first licensed influenza vaccine made using modern recombinant technology.

13 May 2015

Emergency preparedness pays off as Kathmandu hospitals respond to earthquakes

As of today, more than 8200 people are reported to have been killed in the earthquakes and over 19,000 injured...

13 May 2015

Unique rheumatoid arthritis diagnostics tool to launch at Hospitalar 2015

An exclusive solution to improve the diagnosis speed of rheumatoid arthritis - one of the world's five most financially burdensome illnesses for the health insurance systems – will be launched by BGE Systems Ltd at Hospitalar 2015...

13 May 2015

New approach to vaccine development is 97 per cent efficacious and could eliminate shingles

A new vaccine has proven almost completely effective in preventing shingles (disease medical name: herpes zoster), an extremely painful nerve infection which affects a third of Australians; most over the age of 50...

13 May 2015

Researchers present new model for evaluating malaria treatment programs across multiple countries

In a study published this month in Malaria Journal, researchers from Uppsala University and other institutions present a new model for systematically evaluating new malaria treatment programs in routine conditions across multiple countries.

13 May 2015

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

The European Investment Bank (EIB), the world’s largest multilateral bank, today reaffirmed its firm commitment to respond to the Ebola pandemic. The Bank has provided a EUR 50 million loan to Bavarian Nordic, an international biopharmaceutical company, for accelerated development of an Ebola vaccine with long-term efficacy. The financing is also backing research into vaccines for treating other infectious diseases and multiple cancer indications.

12 May 2015

Health workers now have rapid test to detect presence of chikungunya virus within an hour

Scientists at a U.S. Army research center have modified an assay that tests whether or not a sample of mosquitoes harbors the virus responsible for the disease known as chikungunya (CHIKV), long a problem in the Old World tropics but recently established in the Americas.

12 May 2015

Reducing protocol time for 96-well PCR Assays

The virus and prion validation group at Octapharma GmbH (Frankfurt, Germany) reports how implementing an INTEGRA VIAFLO 96 has enabled them to reduce the time taken to undertake PCR assays by greater than 60%...

From INTEGRA Biosciences 12 May 2015

Leicester research team identifies potential new targets for cancer treatments

An international consortium of scientists led by a group from the University of Leicester has announced a new advance in understanding the mechanisms of cancer and how to target it more effectively with new treatments...

12 May 2015

New CLIP-PCR test could help diagnose malaria cases

One of the biggest difficulties faced by worldwide programs aimed at eliminating malaria is that the tests they use are not sensitive enough to detect all people who have the disease and need treatment.

11 May 2015

Raising lupus awareness: an interview with Professor Ramsey-Goldman, MD

Lupus is a chronic, autoimmune disease, with many different symptoms so it is hard to diagnose. It affects each person differently and it has an unpredictable disease course with flare ups and quiet time. Some patients describe lupus as if they are riding a roller coaster with blinders on because they cannot always tell when they will feel well or sick...

11 May 2015

Southern Indiana to be oasis free from Lyme disease, finds Indiana University researcher

Over nearly 15 years spent studying ticks, Indiana University's Keith Clay has found southern Indiana to be an oasis free from Lyme disease, the condition most associated with these arachnids that are the second most common parasitic disease vector on Earth.

11 May 2015

UNC-Chapel Hill, GSK partner to find cure for HIV/AIDS

The University of North Carolina at Chapel Hill, a leading global public research university with significant expertise in HIV basic and clinical research, and GSK, a global, research-based pharmaceutical and healthcare company with a legacy of success in developing treatments for HIV, today announced the creation of the dedicated HIV Cure center and a jointly owned new company that will focus on discovering a cure for HIV/AIDS.

11 May 2015

Researchers discover potential mechanism to combat haemorrhagic diseases

A potential mechanism to combat diseases caused by haemorrhagic fever viruses has been discovered by researchers at the University of Montreal's Department of Biochemistry and Molecular Medicine. These diseases present a dramatic risk to human health as they often spread quickly and kill a high percentage of infected individuals, as demonstrated by the recent Ebola outbreaks.

11 May 2015

Disease/Infection News

UCL-led team develops new technique to find resistant TB faster

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

FDA licenses Protein Sciences' Pearl River, NY facility to manufacture Flublok influenza vaccine

Emergency preparedness pays off as Kathmandu hospitals respond to earthquakes

Unique rheumatoid arthritis diagnostics tool to launch at Hospitalar 2015

New approach to vaccine development is 97 per cent efficacious and could eliminate shingles

Researchers present new model for evaluating malaria treatment programs across multiple countries

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

Health workers now have rapid test to detect presence of chikungunya virus within an hour

Reducing protocol time for 96-well PCR Assays

Leicester research team identifies potential new targets for cancer treatments

New CLIP-PCR test could help diagnose malaria cases

Raising lupus awareness: an interview with Professor Ramsey-Goldman, MD

Southern Indiana to be oasis free from Lyme disease, finds Indiana University researcher

UNC-Chapel Hill, GSK partner to find cure for HIV/AIDS

Researchers discover potential mechanism to combat haemorrhagic diseases

New data driven approach to healthcare

Liberia conducts first polio, measles immunizations since Ebola outbreak.

Gene expression is key to understanding differences between individuals and predisposition to disease

Will the Ebola crisis lead to improved global health security?

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News